- Home
- GDC vs ALXO Comparison
GDC vs ALXO Comparison
Compare GDC & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDC
- ALXO
- Stock Information
- Founded
- GDC 2015
- ALXO 2015
- Country
- GDC United States
- ALXO United States
- Employees
- GDC N/A
- ALXO N/A
- Industry
- GDC Steel/Iron Ore
- ALXO Biotechnology: Pharmaceutical Preparations
- Sector
- GDC Industrials
- ALXO Health Care
- Exchange
- GDC Nasdaq
- ALXO Nasdaq
- Market Cap
- GDC 29.0M
- ALXO 24.0M
- IPO Year
- GDC N/A
- ALXO 2020
- Fundamental
- Price
- GDC $2.96
- ALXO $0.48
- Analyst Decision
- GDC
- ALXO Strong Buy
- Analyst Count
- GDC 0
- ALXO 6
- Target Price
- GDC N/A
- ALXO $3.30
- AVG Volume (30 Days)
- GDC 114.0K
- ALXO 397.6K
- Earning Date
- GDC 08-13-2025
- ALXO 08-07-2025
- Dividend Yield
- GDC N/A
- ALXO N/A
- EPS Growth
- GDC N/A
- ALXO N/A
- EPS
- GDC N/A
- ALXO N/A
- Revenue
- GDC N/A
- ALXO N/A
- Revenue This Year
- GDC N/A
- ALXO N/A
- Revenue Next Year
- GDC N/A
- ALXO N/A
- P/E Ratio
- GDC N/A
- ALXO N/A
- Revenue Growth
- GDC N/A
- ALXO N/A
- 52 Week Low
- GDC $1.03
- ALXO $0.41
- 52 Week High
- GDC $12.18
- ALXO $8.78
- Technical
- Relative Strength Index (RSI)
- GDC 63.36
- ALXO 44.63
- Support Level
- GDC $2.32
- ALXO $0.48
- Resistance Level
- GDC $2.65
- ALXO $0.59
- Average True Range (ATR)
- GDC 0.23
- ALXO 0.05
- MACD
- GDC 0.02
- ALXO -0.00
- Stochastic Oscillator
- GDC 72.73
- ALXO 8.75
About GDC GD Culture Group Limited
GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.